Robuta

Join Intellia Therapeutics in the MAGNITUDE Study, a clinical trial for people living with transthyretin amyloidosis with cardiomyopathy (ATTR-CM).

Background: Hereditary transthyretin-related amyloidosis is a clinically heterogeneous autosomal dominant disease caused by pathogenic variants in the TTR gene...